Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 2/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.36 |
| ▸ | DRD3 | P35462 | 2/20 | 0.36 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | SNCA | P37840 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18582776 | 1.00 | MAPT (0.41) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL2841262 | 1.00 | MAPT (0.41) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL982343 | 1.00 | MAPT (0.41) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL18582741 | 0.94 | MAPT (0.40) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL983577 | 0.94 | MAPT (0.40) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL2842094 | 0.92 | MAPT (0.42) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL18582730 | 0.88 | MAPT (0.39) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL983165 | 0.88 | MAPT (0.39) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL983166 | 0.88 | MAPT (0.39) | MAPTLMNATSHRHIF1AGMNN | |
| SCHEMBL15286195 | 0.84 | MAPT (0.36) | MAPTLMNATSHRHIF1AGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11696920-B2 | Intelligent delivery of ingested and absorbed molecules | IMMD SP. ZO.O (PL) | 2023-07-11 | — | — | US | disclosed |
| CN-114867363-A | Granules comprising a lipid matrix core and an active ingredient | 比利时胶囊公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-102933210-A | Agent for prolonging wake time | MEIJI CO LTD | 2013-02-13 | — | — | CN | disclosed |
| WO-2011118468-A1 | WAKE-TIME-EXTENDING AGENT | 株式会社明治 (JP) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011033884-A1 | PROPHYLACTIC AGENT FOR MUSCULAR CONTRACTURE | 明治乳業株式会社 (JP) | 2011-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696920-B2 | Intelligent delivery of ingested and absorbed molecules | FABP2, FABP1, ELOVL3 | MAPT 3905/4885LMNA 978/4885TSHR 1722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.